{
    "paper_id": "4146f749b0883891603380e62be449df9a94a1a3",
    "metadata": {
        "title": "Supplementary Figures",
        "authors": []
    },
    "abstract": [
        {
            "text": "Supplementary Figure 1: Inhibition of the protease in the FRET-based enzyme activity assay at various concentrations of 1 and 2 in the same ratio as in the ligation assay. Supplementary Figure 2: The LC chromatogram of the ligation of 1 and 2 in different solvents and with or without enzyme present, clearly shows that multiple outcomes of the ligation process are possible and highly depend on the reaction conditions. Supplementary Figure 12: 1 H-and 13 C-NMR spectrum of 8 Supplementary Figure 29: RP-HPLC chromatogram of 21 Supplementary Figure 30: Deconvoluted ESI-MS spectrum of CVB3 3C Pro HPLC-ESI-MS spectra were recorded with an Agilent 1100 LC/MS system equipped with a Luna-C18, 3 \u00b5m by Phenomenex. A gradient of water (solvent A) and acetonitrile (solvent B) was used and each solvent contained 0.1% (vol/vol) formic acid. During the analysis the the solvent ratio (A:B) was changed from 95:5 to 1:99, while maintaining a flowrate of 1 ml/min. Mass spectrometry with 3C Pro -C147A mutant 20 \u00b5L of a 0.425 \u00b5g/ml enzyme solution (containing also 100 mM Tris*HCl, 200 mM NaCl, 4 mM EDTA, 20% glycerine) were incubated with 250 \u00b5M inhibitor for 60 minutes.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Afterwards 10 \u00b5L of this solution were handled as stated in the mass spectrometry of proteininhibitor samples part.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Chymotrypsin 2) Human factor Xa 3) Human Caspase-3 4) 14 > 500 \u00b5M > 500 \u00b5M > 500 \u00b5M > 500 \u00b5M 20 > 500 \u00b5M > 500 \u00b5M > 500 \u00b5M > 300 \u00b5M 1) in 50 mM MOPS-NaOH pH 8.0 / 154 mM NaCl with 57 \u00b5M tert. butyloxycarbonyl (Boc)-LGR-7-amino-4methylcoumarin (AMC) as substrate; 2) in 50 mM MOPS-NaOH pH 8.0 / 154 mM NaCl with 1.6 mM AF-AMC as substrate. 3) in 50 mM MOPS-NaOH pH 8.0 / 154 mM NaCl with 114 \u00b5M Boc-LGR-AMC as substrate; 4) in 50 mM HEPES-NaOH pH 7.5 / 100 mM NaCl / 1 mM EDTA / 0.1% (w/v) CHAPS / 10% (v/v) glycerol /2 mM DTT with 10 \u00b5M acetyl-DEVD-AMC as substrate;",
            "cite_spans": [
                {
                    "start": 51,
                    "end": 53,
                    "text": "4)",
                    "ref_id": null
                },
                {
                    "start": 132,
                    "end": 134,
                    "text": "1)",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 263,
                    "end": 265,
                    "text": "2)",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 339,
                    "end": 341,
                    "text": "3)",
                    "ref_id": null
                },
                {
                    "start": 420,
                    "end": 422,
                    "text": "4)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Identity and purity (>95%) of all compounds were determined by chromatography (silica or RP-18 HPLC), by fully assigned 1 H-and 13 C NMR spectra (see supplementary NMR spectra) and by high-resolution mass spectra. Solvents were purchased in p.a. quality by VWR ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "General synthetic information"
        },
        {
            "text": "Purification with high performance liquid chromatography was performed with an Agilent 1260 Infinity Binary LC System equipped with a Nucleodur C18 HTec, 5 \u00b5m by Macherey Nagel (D\u00fcren, Germany). A gradient from water and acetonitrile (with 0.1% trifluoroacetic acid respectively) was utilized to separate the compounds.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Chromatographic methods"
        },
        {
            "text": "Flash chromatography was performed with an Isolera One System from Biotage (Upsala, Sweden) using pre-packed KP-Sil SNAP-cartridges.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Chromatographic methods"
        },
        {
            "text": "The electrophilic probe 1 has been synthesized according to the procedure of Marigo et al. 1",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Ethyl (2S,3S)-epoxy-4-oxo-butanoate 1"
        },
        {
            "text": "A mixture of 2-cyanoacetyl hydrazide (1.25 g, 12.7 mmol) and cycloheptanone (1.42 g, 12.7 mmol) was heated in ethanol (12 ml ",
            "cite_spans": [
                {
                    "start": 76,
                    "end": 89,
                    "text": "(1.42 g, 12.7",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "5-Amino-1-cycloheptyl-1,2-dihydro-pyrazol-3-one 2 2"
        },
        {
            "text": "Ethyl (2S,3S)-epoxy-4-oxo-butanoate (50 mg, 0.34 mmol, 1 eq) was dissolved in 1,2dichloroethane (5 ml). After addition of 2 (50 mg, 0.25 mmol, 0.75 eq) in methanol (1 ml ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "O-Ethyl 4-[(5-amino-1-cycloheptyl-1,2-dihydropyrazol-3-one-4-yl]-(2S,3R)-epoxybutanoate 3"
        },
        {
            "text": "2 (1 eq) was dissolved in pyridine (10 ml per 0.5 mg 2) and stirred vigorously. Trans-2,3-Epoxysuccinic acid (2.95 eq) and N,N'-dicyclohexylcarbodiimide (2.95 eq) was added and the suspension stirred overnight. The solvent was removed in vacuo, the residue was taken up in ethanol and aqueous sodium hydroxide solution (2 mol/l, 2 eq) was added dropwise. After 30 minutes of stirring, the solvent was removed in vacuo, after which the residue was taken up in aqueous acetonitrile, filtered and purified with reversed phase liquid chromatography, which (2), 27.9 (2), 23,9 (2), 13.9; mp.: > 250\u00b0C (decomp.). 163.8, 160.5, 134,8, 84.8, 61.1, 56.4, 53.7, 52.4, 34.3, 34.2, 27.8 (2) , 23.9 (2), 13.9; mp.: 70-71\u00b0C.",
            "cite_spans": [
                {
                    "start": 607,
                    "end": 678,
                    "text": "163.8, 160.5, 134,8, 84.8, 61.1, 56.4, 53.7, 52.4, 34.3, 34.2, 27.8 (2)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "epoxy-butanoate 4"
        },
        {
            "text": "Trans-epoxysuccinic acid (=2,3-epoxybutanediacid, 200 mg, 1. 128.4, 126.9, 126.4, 125.9, 123.9, 57.0, 53.5, 52.9, 40.9, 34.7 (2), 28.3 (2), 24.4 (2) two carbonyl atoms and C-4 could not be resolved. mp.: 141-142\u00b0C.",
            "cite_spans": [
                {
                    "start": 61,
                    "end": 124,
                    "text": "128.4, 126.9, 126.4, 125.9, 123.9, 57.0, 53.5, 52.9, 40.9, 34.7",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "N-(1-Cycloheptyl-1,2,5-dihydro-1H-pyrazol-3-one-5-yl)-N\u00b4-(naphth-1yl)-(2R,3R)/(2S,3S)-epoxy-butanediamide 6"
        },
        {
            "text": "Ethyl (2E)-4-oxo-2-butenoate (62 \u00b5l, 0.5 mmol, 1 eq) was dissolved in methanol (15 ml).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "O-Ethyl 4-(5-Amino-1-cycloheptyl-1,2-dihydropyrazol-3-one-4-yl)-2E-butenoate 7"
        },
        {
            "text": "After addition of 2 (100 mg, 0. 5 mmol, 0.1 eq) sodium cyanoborohydride (62 mg, 1 mmol, 2 eq) was added and the solution was stirred for twelve hours. The reaction was quenched with water, the solvent removed in vacuo and the residue was purified with reversed phase high performance liquid chromatography, yielding 7 as a white solid. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "O-Ethyl 4-(5-Amino-1-cycloheptyl-1,2-dihydropyrazol-3-one-4-yl)-2E-butenoate 7"
        },
        {
            "text": "2 (120 mg, 0.61 mmol, 1 eq) was dissolved in ice cooled acetic acid (5 ml (2), 29.1 (2), 25.1 (2).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "O-Ethyl 4-(5-amino-1-cycloheptyl-1,2-dihydropyrazol-3-one-4-yl)-4-oxo-2E-butenoate 8"
        },
        {
            "text": "70 \u00b5mol, 1 eq) was dissolved in 20 ml ethanol. Catalytic amounts of N,N-dimethylformamide were added and oxalylchloride (7.2 \u00b5l, 84 \u00b5mol, 1.2 eq) were added dropwise with vigorous stirring. The reaction mixture was stirred overnight after which the solvents were evaporated.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "4-(5-amino-1-cycloheptyl-3-oxo-1,2-dihydropyrazol-4-yl)-4-oxo-2E-butenoic acid (20.8 mg,"
        },
        {
            "text": "The residue was purified with reversed phase-high performance liquid chromatography, furnishing 9 as a colorless solid. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "4-(5-amino-1-cycloheptyl-3-oxo-1,2-dihydropyrazol-4-yl)-4-oxo-2E-butenoic acid (20.8 mg,"
        },
        {
            "text": "5-Amino-1-phenyl-1.2-dihydropyrazol-3-one (175 mg, 1 mmol, 1 eq) was dissolved in 7 ml 1,4-dioxane and transferred to a microwave vessel (pressure stable, max. volume 10 ml).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "O-Ethyl 4-(5-amino-1-phenyl-1,2-dihydropyrazol-3-one-4-yl)-4-oxo-2E-butenoate 10"
        },
        {
            "text": "Maleic anhydride (147 mg, 1.5 mmol, 1.5 eq) was added, the vessel was sealed with a septum and placed in an Initiator + microwave reactor from Biotage (Uppsala, Sweden 1, 165.5, 139.3, 129.6 (2), 129.4, 127.6, 127.4, 123.5 (2) , 93.7, 60.7, 14.1 2 carbonyle signals could not be resolved; mp.: > 220\u00b0C (decomp.)",
            "cite_spans": [
                {
                    "start": 168,
                    "end": 226,
                    "text": "1, 165.5, 139.3, 129.6 (2), 129.4, 127.6, 127.4, 123.5 (2)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "O-Ethyl 4-(5-amino-1-phenyl-1,2-dihydropyrazol-3-one-4-yl)-4-oxo-2E-butenoate 10"
        },
        {
            "text": "2 (66 mg, 0.34 mmol, 1 eq) was dissolved in pyridine (3 ml) 1, 154.2, 147.1, 135.5, 133.1, 80.6, 61.8, 57.7, 35 .0 (2), 28.8 (2) 6, 164.2, 161.8, 135.6, 135.3, 128.3, 85.9, 61.5, 58.1, 35.6 (2) , 28.9 (2), 25.1 (2), 14.4; mp: 148-149\u00b0C.",
            "cite_spans": [
                {
                    "start": 53,
                    "end": 59,
                    "text": "(3 ml)",
                    "ref_id": null
                },
                {
                    "start": 60,
                    "end": 111,
                    "text": "1, 154.2, 147.1, 135.5, 133.1, 80.6, 61.8, 57.7, 35",
                    "ref_id": null
                },
                {
                    "start": 129,
                    "end": 193,
                    "text": "6, 164.2, 161.8, 135.6, 135.3, 128.3, 85.9, 61.5, 58.1, 35.6 (2)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "O-(5-Amino-1-cycloheptyl-1H-pyrazol-3-yl)-O\u00b4-ethyl but-2E-enedioate 11"
        },
        {
            "text": "Maleamic acid (1.61 g, 14 mmol, 1 eq) was djssolved in EtOH. Concentrated sulfuric acid (0.15 ml, 0.2 eq) was added and the mixture was refluxed for 2.5 h. After removal of the solvent the white precipitate was purified over silica by MPLC with ethyl acetate/n-hexane 12, 165.82, 132.86, 127.53, 60.08, 13.88; mp: 94 (2), 131.8 (2), 33.6 (2), 14.4 (2) .",
            "cite_spans": [
                {
                    "start": 268,
                    "end": 316,
                    "text": "12, 165.82, 132.86, 127.53, 60.08, 13.88; mp: 94",
                    "ref_id": null
                },
                {
                    "start": 348,
                    "end": 351,
                    "text": "(2)",
                    "ref_id": "BIBREF25"
                }
            ],
            "ref_spans": [],
            "section": "O-Ethyl 3-carbamoyl-2Z-propenoate 13"
        },
        {
            "text": "Compound 2 (100 mg, 0.5 mmol, 1 eq) and benzotriazol- ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "N-(1-Cycloheptyl-1,2-dihydropyrazol-3-one-5-yl)-prop-2-enamide 16"
        },
        {
            "text": "According to the synthetic procedure for 2, 5-Amino-1-(4-heptyl)-1,2-dihydropyrazol-3-one was prepared by the reaction of 4-heptanone and 2-cyanoacetyl hydrazide, which yielded the desired pyrazolone after reduction with sodium borohydride. 1, 73.3, 54.5, 36.3 (2) , 18.9 (2), 13.9 (2); mp.: > 208\u00b0C (decomp.).",
            "cite_spans": [
                {
                    "start": 241,
                    "end": 264,
                    "text": "1, 73.3, 54.5, 36.3 (2)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Ethyl N-(1-(4-heptyl)-1,2-dihydropyrazol-3-one-5-yl)-carbamoyl-2Z-propenoate 17"
        },
        {
            "text": "5-Amino-1,2-dihydro-3H-pyrazol-3-one 3 (350 mg, 3.55 mmol, 1 eq) was dissolved in acetic acid (30 ml) and cooled with an ice bath. Maleic anhydride (765 mg, 7.8 mmol, 2.2 eq) was 5, 166.1, 165.3, 158.3, 131.3, 128.9, 60.3, 33.9, 13.8; mp.: 63-64\u00b0C ",
            "cite_spans": [
                {
                    "start": 179,
                    "end": 247,
                    "text": "5, 166.1, 165.3, 158.3, 131.3, 128.9, 60.3, 33.9, 13.8; mp.: 63-64\u00b0C",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Ethyl N-(1H-1,2-dihydropyrazol-3-one-5-yl)-3-carbamoyl-2Z-propenoate 18"
        }
    ],
    "bib_entries": {
        "BIBREF2": {
            "ref_id": "b2",
            "title": "COOCH 2 CH 3 , 2H), 4.09 (m, NCH(CH 2 ) 2 , 1H), 3.50 (s, NNHCO, 1H), 1.69 (m, heptyl-CH 2 , 2H), 1.57 -1.46 (m, heptyl-CH 2 , 2H), 1.19 (t",
            "authors": [
                {
                    "first": "J H-H =",
                    "middle": [],
                    "last": "11",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "NHCOCHCHCOOEt, 1H), 6.38 (d, 3 J H-H = 11.9 Hz, NHCOCHCHCOOEt, 1H), 5.50 (s, NNHCOCHCN, 1H), 4.12 (q, 3 J H-H = 7.2 Hz",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "mg, 70 \u00b5mol, 1 eq) was dissolved in ethanol (20 ml) and N,N-dimethylformamide (2 \u00b5l) and oxalyl chloride (7.2 \u00b5l, 84 \u00b5mol, 1.2 eq) were added under vigorous stirring. The solution was stirred overnight after which the solvents were removed in vacuo and the residue purified with high performance liquid chromatography",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "COOCH 2 CH 3 , 2H), 4.09 (m, NCH(CH 2 ) 2 , 1H), 3.50 (s, NNHCO, 1H), 1.69 (m, heptyl-CH 2 , 2H), 1.57 -1.46 (m, heptyl-CH 2 , 2H), 1.19 (t",
            "authors": [
                {
                    "first": "J H-H =",
                    "middle": [],
                    "last": "11",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "NHCOCHCHCOOEt, 1H), 6.38 (d, 3 J H-H = 11.9 Hz, NHCOCHCHCOOEt, 1H), 5.50 (s, NNHCOCHCN, 1H), 4.12 (q, 3 J H-H = 7.2 Hz",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "-Cycloheptyl-1,2-dihydropyrazol-3-one-5-yl)-N\u00b4-(2-naphthyl)methyl-2Z-butenediamide 19",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Maleic anhydride (310 mg, 3.1 mmol, 1 eq) was added slowly and the solution was stirred overnight. The solvent was evaporated and the residue purified with normal phase flash chromatography using a gradient of methylene chloride and methanol",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "100",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "v/v) as eluent, which furnished 4-[(Naphthalene-2-ylmethyl)amino]-4-oxo-2Z-butenoic acid as a colorless solid",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "500 MHz, DMSO-d 6 ): \u03b4 [ppm] = 9.53 (t, 3 J H-H = 5.8 Hz, NH, 1H), 7.94 -7.84 (m, ArH, 2H), 7.83 (s, ArH, 1H), 7.54 -7.44 (m, ArH, 2H), 7.43 -7",
            "authors": [
                {
                    "first": "; H-Nmr",
                    "middle": [],
                    "last": "Da",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "The acidic proton of the carboxylic acid could not be resolved. 13 C-NMR (125 MHz, DMSO-d 6 ): \u03b4",
            "authors": [
                {
                    "first": "J H-H = 5",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Naphthalene-2-ylmethyl)amino]-4-oxo-2Z-butenoic acid (306 mg, 1.2 mmol, 2.4 eq), 4-dimethylaminopyridine (1.2 mg, 0.01 mmol, 0.02 eq) and N,N'-dicyclohexylcarbodiimide (248 mg, 1.2 mmol, 2.4 eq) were added. The suspension was stirred overnight after which it was filtered and the solvents were coevaporated with toluene. The residue was dissolved in ethanol (10 ml) and aqueous sodium hydroxide solution (5 mol/l, 112 \u00b5l, 0.56 mmol, 1.1 eq) was added. The solution was stirred for 30 minutes, the solvents were evaporated and the residue purified with reversed phase high performance liquid chromatography",
            "authors": [],
            "year": null,
            "venue": "mg, 0.5 mmol, 1 eq) was dissolved in pyridine (10 ml) and",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "2 , 1H), 7.91 -7.79 (m, ArH, 2H), 7.69 (s, ArH, 1H), 7.53 -7.41 (m, ArH, 2H), 7.46 -7.35 (m, ArH, 2H)",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Hz",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "1 eq) was dissolved in pyridine (10 ml) and N,N'-dicyclohexylcarbodiimide (206 mg, 1 mmol, 1 eq) and (E)-3-(phenylsulfonyl)acrylic acid 4 (212 mg, 1 mmol, 1 eq) were added subsequently. The suspension was stirred overnight, filtered and dried in vacuo. Purification of the residue with reversed phase high performance liquid chromatography",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "NCNHCO, 1H), 9.66 (s, NNHCO, 1H), 8.02 -7.93 (m, phenylH, 2H), 7.84 -7.76 (m, phenylH, 1H), 7.72 (m, phenylH, 2H), 7.68 (d, 3 J H-H = 15.0 Hz, NHCOCHCHSO 2 Ph, 1H), 7.34 (d, 3 J H-H = 15.0 Hz, NHCOCHCHSO 2 Ph, 1H), 5.60 (s, NNHCOCH, 1H), 4.25 (tt, 3 J H-H = 8.7, 5.5 Hz, NCH(CH 2 ) 2 , 1H), 1.81 (m, cycloheptyl-CH 2 , 4H)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "-Isopropyl-1,2-dihydropyrazol-3-one-5-yl)-3-(phenylsulfonyl)-2E-prop-ene-amide 21",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "21 was prepared according to the synthetic procedure for 10, using 5-Amino-1-(4-isopropyl)-1,2-dihydropyrazol-3-one as starting material",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "1014 Da; 1 H-NMR (500 MHz, DMSO-d 6 ): \u03b4 [ppm] = 10.82 (s, NCNHCO, 1H)",
            "authors": [],
            "year": null,
            "venue": "10.56 (s, NNHCO, 1H), 7.89 (m, J H-H = 10.8, 8.5, 1.3 Hz, phenylH, 2H), 7.84 -7.75 (m, phenyl-H, 1H), 7.70 (d, 3 J H-H = 15.1 Hz, NHCOCHCHSO2Ph, 1H)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "6 Hz, isopropyl-CH 3 , 6H); 13 C-NMR (125 MHz, DMSO-d 6 ): \u03b4",
            "authors": [
                {
                    "first": "J H-H = 6",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Asymmetric organocatalytic epoxidation of alpha,beta-unsaturated aldehydes with hydrogen peroxide",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Marigo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Franzen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Poulsen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhuang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Jorgensen",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J. Am. Chem. Soc",
            "volume": "127",
            "issn": "",
            "pages": "6964--6965",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "A new method for the synthesis of 1-substituted 5-amino-3-hydroxypyrazoles",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Gyulbudaghyan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Hakopyan",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Vartanyan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Sheyranyan",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Chem. J. Arm",
            "volume": "55",
            "issn": "",
            "pages": "58--62",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "The hydrazinolysis of heterocyclic compounds. II. 6-Amino-4-hydroxy-1-methylpyrimidine-2(1H)-thione and related compounds",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Dickinson",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "W"
                    ],
                    "last": "Jacobsen",
                    "suffix": ""
                }
            ],
            "year": 1975,
            "venue": "Aust. J. Chem",
            "volume": "28",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "An Economical and Convenient Synthesis of Vinyl Sulfones",
            "authors": [
                {
                    "first": "Z.-H",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zuo",
                    "suffix": ""
                },
                {
                    "first": "L.-B",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Z.-H",
                    "middle": [],
                    "last": "Ren",
                    "suffix": ""
                },
                {
                    "first": "Y.-M",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Synthesis",
            "volume": "",
            "issn": "",
            "pages": "1465--1470",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "A,B: Binding conformation of the inhibitors 12 (A) and 20 (B) in the active site of CVB3 3C protease generated by docking experiments. C,D: Structures of inhibitors 12 (C) and 20 (D) with the carbon participating in the covalent protease reaction highlighted by an asterisk. Supplementary Figure 4: 1 H-NMR spectrum of 1 Supplementary Figure 9: [ 1 H, 13 C]-HSQC-NMR spectrum of 5 Supplementary Figure 13: [ 1 H, 13 C]-HMBC-NMR spectrum of 8 Supplementary Figure 35: Deconvoluted ESI-MS spectrum of CVB3 3C Pro with 20 Supplementary Figure 36: Stereo image of the electron density map of the crystal structure of inhibitor 14 bound to the active site of EV-B93 3C protease (PDB: 5IYT): \u03c3\u00c5-weighted 2Fo-Fc electron density map, contoured at the 0.9\u03c3 level, of the EV-B93 3C protease active site showing the final refined model in sticks (protein: carbon atoms shown in grey; inhibitor 14: carbon atoms shown in yellow).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "acid as a colorless intermediate. This was dissolved in ethanol, mixed with two drops of concentrated sulfuric acid and stirred at 90\u00b0C for 60 minutes. After cooling, the solvent was removed in vacuo and the residue purified with reversed phase liquid chromatography. Depending on the configuration of the employed epoxysuccinic acid, an enantiomeric mixture of (2R,3R)/(2S,3S) 4 from trans-epoxysuccinic acid and (2R,3S)/(2S,3R) 5 from cisepoxysuccinic acid was obtained.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "mg, 1.22 mmol, 2 eq) was added and the solution stirred overnight. The solvent was removed in vacuo and the residue purified with flash chromatography (dichloromethane:methanol, 95:5, v/v) which yielded (E)-4-(5-amino-1-cycloheptyl-3-oxo-1,2-dihydropyrazol-4-yl)-4-oxo-2-butenoic acid as a side product. The carboxylic acid was dissolved in ethanol (5 ml) and mixed with two drops of concentrated sulfuric acid. The solution was heated to 90\u00b0C for 60 minutes. Removal of the solvent in vacuo and purification with reversed phase high performance liquid chromatography furnished 8 as a yellow solid.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "-Ethyl N-(1-cycloheptyl-1,2-dihydropyrazol-3-one-5-yl)-3-carbamoyl-2Z-propenoate 12Compound 2 (120 mg (0.61 mmol, 1 eq) was dissolved in acetic acid (5 ml) cooled in an ice bath. Maleic anhydride (120 mg, 1.22 mmol, 2 eq) was added and the solution was stirred overnight. The solvent was removed in vacuo and the residue purified with flash chromatography (dichloromethane:methanol, 95:5) which yielded4-((1-cycloheptyl-1,2-   dihydropyrazol-3-one-5-yl)-amino)-4-oxo-2Z-butenoic acid as an off-white solid.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "-Ethyl, N\u00b4-(1-cycloheptyl-1,2-dihydropyrazol-3-one-5-yl)-2Z-butene-diamide 14 4-((1-cycloheptyl-1,2-dihydropyrazol-3-one-5-yl)-amino)-4-oxo-2Z-butenoic acid (50 mg, 0.17 mmol, 1 eq; see synthesis of 12) was dissolved under argon in THF (5 ml). After the addition of thionyl chloride (18 \u00b5l, 2.5 mmol, 1.4 eq) and DMF (100 \u00b5l) the solution was stirred for 10 minutes. An aqueous ethylamine solution (1 ml, 30 wt.%) was added and the solution stirred for an additional two hours. The solvent was removed in vacuo and the residue subjected to reversed phase high performance liquid chromatography, which yielded product 14 as a slightly yellow solid.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "added and the solution was stirred overnight. The solvent was removed in vacuo and the residue taken up in ethanol (30 ml). Thionyl chloride (386 \u00b5l, 5.3 mmol, 1.5 eq) was added dropwise and the solution was stirred overnight. Removal of the solvent in vacuo and purification of the residue via reversed phase high performance liquid chromatography furnished 18 as a colorless solid. Yield: 80 mg (10%); ESI-MS (m/z): [M+H] + calc. for C 9 H 12 N 3 O 4 + , 226.1 Da; found, 226.0 Da; 1 H-NMR (500 MHz, DMSO-d 6 ): \u03b4 [ppm] = 11.21 (s, NH, 1H), 10.91 (s, NH, 1H), 6.37 (d, 3 J H-H = 12.0 Hz, COCHCHCOOEt, 1H), 6.34 (d, 3 J H-H = 12.0 Hz, COCHCHCOOEt, 1H), 4.91 (s, NHNHCOCHC, 1H), 4.02 (q, 3 J H-H = 7.1 Hz, COOCH 2 CH 3 , 2H), 1.14 (t, 3 J H-H = 7.1 Hz, COOCH 2 H 3 , 3H); 13 C-NMR (125 MHz, DMSO-d 6 ): \u03b4 [ppm] = 166.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "SupplementaryTable 1.",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "GmbH) were used for NMR spectroscopy. Chemicals were purchased from Sigma Aldrich, Carl Roth GmbH & Co. KG, Merck KGaA (Darmstadt, Germany), Alfa Aesar (Karlsruhe, Germany), ABCR GmbH & Co. KG (Karlsruhe, Germnay), and Fluka Chemie GmbH (Buchs, Switzerland) with the highest purity and used without further purification.HPLC was performed with an Agilent 1260 Infinity Binary LC System equipped with a Nucleodur C18 HTec, 5 \u00b5m by Macherey Nagel (D\u00fcren, Germany). NMR was performed with a Jeol ECP500 or a Bruker AvanceIII 700 spectrometre with deuterated solvents purchased from Eurisotop (Saint-Aubin Cedex, France).",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": ") under reflux for 1 h. After cooling, the precipitate was filtered off, washed with cold ethanol, recrystallized from ethanol and dried under vacuum.",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": "dimethylformamide (15 ml). 1-Naphthylmethylamine (183 \u00b5l, 1.25 mmol, 1 eq) was added dropwise and the solution stirred until a white precipitate was formed. The suspension was filtered and the filtrate dried in vacuo. The residue was passed through a short pad of silica using an eluent consisting of methylene chloride and methanol (DCM:MeOH, 9:1 v/v). This and N,N'-dicyclohexylcarbodiimide (181 mg, 0.88 mmol, 1eq) was added. The resulting suspension was stirred for 16 hours after which it was filtered and dried in vacuo. The residue was washed with toluene and remaining solvents were coevaporated with toluene. The dried residue was dissolved in ethanol and sodium hydroxide (17.5 mg, 0.44 mmol, 1 eq) was added. After stirring for one hour the suspension was filtered, dried in vacuo and the residue subjected to normal phase flash chromatography using an hexane-ethylacetat gradient (1:0 \u00e0 0:1) as eluent, furnishing 6 as a white solid.",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "eq) were added. After two hours of stirring aqueous sodium hydroxide solution (5 ml, 2 mol/l) was added dropwise and the reaction mixture was stirred overnight. The suspension was filtered, adjusted to pH 1 with diluted hydrochloric acid and washed with ethyl acetate. The organic phase was dried in vacuo and the residue subjected to high",
            "latex": null,
            "type": "table"
        },
        "TABREF10": {
            "text": "Afterwards the solution was cooled and the solvent removed in vacuo. The residue was taken up in ethanol (15 ml) and a catalytic amount of concentrated sulfuric acid was added dropwise. After refluxing the solution for twelve hours, the solvent was evaporated and the residue subjected to reversed phase high performance liquid chromatography, which furnished",
            "latex": null,
            "type": "table"
        },
        "TABREF14": {
            "text": "N-Ethylmaleic acid (421 mg, 2.5 mmol, 1 eq) and N,N-diisopropylethylamine(1.7 ml, 10    mmol, 4 eq) were mixed in N,N-dimethylformamide (10 ml). Ethylamine hydrochloride (205 mg, 2.5 mmol, 1 eq) and HATU coupling reagent (1.425 g, 3.75 mmol, 1.5 eq) were added and the solution was stirred for four hours. Afterwards the solution was diluted with ethyl acetate and washed six times with 5% aqueous potassium carbonate solution. The organic phase was dried with magnesium sulfate, filtered and evaporated to dryness.Normal phase flash chromatography (dichloromethane:methanol, 95:5 v/v) of the residue furnished N,N 'diethylmaleic diamide 15 as a colorless liquid. CHCONH, 2H), 3.13 (q, 3 J H-H = 7.3 Hz, NHCH 2 CH 3 , 4H), 1.05 (t, 3 J H-H = 7.3 Hz, NHCH 2 CH 3 , 6H); 13 C-NMR (100 MHz, DMSO-d 6 ): \u03b4 [ppm] = 164.4",
            "latex": null,
            "type": "table"
        },
        "TABREF15": {
            "text": "1-ol (150 mg, 1.1 mmol, 2.2 eq)    were dissolved in pyridine (10 ml) and N,N'-dicyclohexylcarbodiimide (226 mg, 1.1 mmol, 2.2 eq) was added. Acrylic acid (75 \u00b5l, 1.1 mmol, 2.2 eq) was added dropwise and the suspension was stirred overnight. The reaction mixture was poured into cold hexane and the precipitation was filtered, dried and dissolved in ethanol. After addition of aqueous sodium hydroxide solution (1 ml, 1 mol/l) the mixture was stirred for three hours. The solvents were removed in vacuo and the residue purified with normal phase flash chromatography using a gradient of methylene chloride-methanol (100:0 \u00e0 90:10) as eluent. This furnished 16 as a colorless solid.",
            "latex": null,
            "type": "table"
        },
        "TABREF16": {
            "text": "Yield: 1.0 g (80%); ESI-MS (m/z): [M-H] + calc. for C 10 H 18 N 3 O + , 196.1 Da; found, 196.1 Da; 1 H-NMR (500 MHz, DMSO-d 6 ): \u03b4 [ppm] = 9.54 (s, -NH, 1H), 5.29 (s, -NH 2 , 2H), 4.37 (s, COCH, 1H), 3.82 (tt, NCH(CH 2 ) 2 , 1H), 1.65-1.58 (m, CH 2 , 2H), 1.43-1.35 (m, CH 2 , 2H), 1.20-1.13 (m, CH 2 , 2H), 1.13-1.03 (m, CH 2 , 2H), 0.81 (t, CH 3 , 6H); 13 C-NMR (125 MHz, DMSO-d 6 ): \u03b4 [ppm]= 162.9, 151.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}